Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$1.04B |
| 2 |
Palo Alto Networks
PANW
|
+$957M |
| 3 |
Medtronic
MDT
|
+$433M |
| 4 |
Pinterest
PINS
|
+$422M |
| 5 |
Colgate-Palmolive
CL
|
+$396M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.38B |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$967M |
| 3 |
Apple
AAPL
|
+$847M |
| 4 |
Meta Platforms (Facebook)
META
|
+$700M |
| 5 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$576M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.9% |
| 2 | Financials | 7.33% |
| 3 | Healthcare | 6.04% |
| 4 | Consumer Discretionary | 5.46% |
| 5 | Communication Services | 3.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2026
Vanguard Short-Term Corporate Bond ETF
VCSH
$44.6B
| $1.43M | ﹤0.01% |
18,760
| – | – |
|
2027
Primerica
PRI
$9.89B
| $1.43M | ﹤0.01% |
11,941
-1,773
| -13% | -$223K |
|
2028
XPO
XPO
$23.1B
| $1.43M | ﹤0.01% |
49,926
+2,720
| +6% | +$86.5K |
|
2029
Nano X Imaging
NNOX
$76.6M
| $1.43M | ﹤0.01% |
126,301
+125,734
| +22,175% | +$1.31M |
|
|
AEL
2030
DELISTED
American Equity Investment Life Holding Company
AEL
| $1.42M | ﹤0.01% |
38,804
-38,650
| -50% | -$1.47M |
|
|
RBCP
2031
DELISTED
RBC Bearings Incorporated 5.00% Series A Mandatory Convertible Preferred Stock
RBCP
| $1.42M | ﹤0.01% |
15,000
-22,750
| -60% | -$2.12M |
|
|
CVAC
2032
DELISTED
CureVac
CVAC
| $1.42M | ﹤0.01% |
104,006
+22,161
| +27% | +$367K |
|
|
PANA
2033
DELISTED
Panacea Acquisition Corp. II Class A Ordinary Shares
PANA
| $1.41M | ﹤0.01% |
+144,682
| New | +$1.41M |
|
2034
Integer Holdings
ITGR
$4.23B
| $1.41M | ﹤0.01% |
19,971
-16,061
| -45% | -$1.23M |
|
|
SVFA
2035
DELISTED
SVF Investment Corp. Class A Ordinary Shares
SVFA
| $1.41M | ﹤0.01% |
142,763
-1,100
| -0.8% | -$10.8K |
|
2036
OSI Systems
OSIS
$3.72B
| $1.41M | ﹤0.01% |
16,452
-8,235
| -33% | -$676K |
|
2037
Dolby
DLB
$5.59B
| $1.4M | ﹤0.01% |
19,610
+4,902
| +33% | +$371K |
|
2038
PRA Group
PRAA
$666M
| $1.4M | ﹤0.01% |
38,600
-19,433
| -33% | -$770K |
|
2039
TG Therapeutics
TGTX
$7.07B
| $1.4M | ﹤0.01% |
329,769
+189,478
| +135% | +$1.18M |
|
|
AFAC
2040
DELISTED
Arena Fortify Acquisition Corp. Class A Common Stock
AFAC
| $1.4M | ﹤0.01% |
140,200
| – | – |
|
2041
Power Integrations
POWI
$3.37B
| $1.4M | ﹤0.01% |
18,645
+7,114
| +62% | +$577K |
|
2042
Atkore
ATKR
$3.16B
| $1.4M | ﹤0.01% |
16,842
-3,032
| -15% | -$301K |
|
2043
HSBC
HSBC
$370B
| $1.4M | ﹤0.01% |
42,812
-6,163
| -13% | -$200K |
|
2044
Comscore
SCOR
$108M
| $1.39M | ﹤0.01% |
33,804
+26,878
| +388% | +$1.12M |
|
|
IPOF
2045
DELISTED
Social Capital Hedosophia Holdings Corp. VI
IPOF
| $1.39M | ﹤0.01% |
140,310
-10,000
| -7% | -$101K |
|
2046
Teck Resources
TECK
$29.5B
| $1.39M | ﹤0.01% |
45,538
+11,048
| +32% | +$436K |
|
2047
Unifirst Corp
UNF
$5.27B
| $1.39M | ﹤0.01% |
8,083
-7,682
| -49% | -$1.28M |
|
2048
Clearway Energy Class C
CWEN
$4.99B
| $1.39M | ﹤0.01% |
39,958
+7,164
| +22% | +$241K |
|
|
QUOT
2049
DELISTED
Quotient Technology Inc
QUOT
| $1.39M | ﹤0.01% |
467,985
-141,903
| -23% | -$673K |
|
2050
Ironwood Pharmaceuticals
IRWD
$728M
| $1.39M | ﹤0.01% |
120,507
-335,591
| -74% | -$3.95M |
|
Similar funds
Barclays's Q2 2022 Portfolio in Review
As of Q2 2022, Barclays held 5,544 positions worth $163B, up 28% from $128B the previous quarter. Its ten largest holdings account for 39% of the portfolio.
Barclays deployed $63.1B of net new capital in Q2 2022, opening 561 new positions and adding to 1,332 existing holdings. Its largest new stake was Fisker Inc.: 3,607,227 shares worth $30.9M.
By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 22% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1.38B trimmed.
- Barclays's largest Q2 2022 buy was Fisker Inc.: 3,607,227 shares worth $30.9M.
- Barclays added most to State Street Consumer Discretionary Select Sector SPDR ETF in Q2 2022, an estimated $1.04B increase.
- Barclays's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.38B.
- Barclays fully exited Cerner Corp in Q2 2022, selling an estimated $432M.
- Barclays's ten largest holdings make up 39% of its $163B portfolio in Q2 2022.
- Barclays opened 561 new positions and closed 413 in Q2 2022.
- Barclays's portfolio value rose 28% quarter-over-quarter to $163B.
Based on Barclays's 13F filing for Q2 2022, filed 12 Aug 2022.